Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Microbot Medical ( (MBOT) ) has issued an update.
On June 5, 2025, Microbot Medical announced its selection for preliminary inclusion in the Russell Microcap® Index, as published by FTSE Russell on May 23, 2025. This inclusion, effective after the U.S. market closes on June 27, 2025, signifies a notable milestone for the company, potentially enhancing its visibility among investment managers and institutional investors who use Russell indexes as benchmarks for approximately $10.6 trillion in assets.
The most recent analyst rating on (MBOT) stock is a Buy with a $9.00 price target. To see the full list of analyst forecasts on Microbot Medical stock, see the MBOT Stock Forecast page.
More about Microbot Medical
Microbot Medical Inc. is a pre-commercial stage medical technology company focused on improving healthcare quality globally. It has developed the world’s first single-use, fully disposable endovascular robotic system, aiming to overcome traditional barriers to advanced robotic systems.
Average Trading Volume: 2,448,864
Technical Sentiment Signal: Buy
Current Market Cap: $99.31M
See more insights into MBOT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue